Literature DB >> 20186852

Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation.

Hans Knoblauch1, Christian Geier, Stephanie Adams, Birgit Budde, André Rudolph, Ute Zacharias, Jeannette Schulz-Menger, Andreas Spuler, Rabah Ben Yaou, Peter Nürnberg, Thomas Voit, Gisele Bonne, Simone Spuler.   

Abstract

We investigated a large German family (n = 37) with male members who had contractures, rigid spine syndrome, and hypertrophic cardiomyopathy. Muscle weakness or atrophy was not prominent in affected individuals. Muscle biopsy disclosed a myopathic pattern with cytoplasmic bodies. We used microsatellite markers and found linkage to a locus at Xq26-28, a region harboring the FHL1 gene. We sequenced FHL1 and identified a new missense mutation within the third LIM domain that replaces a highly conserved cysteine by an arginine (c.625T>C; p.C209R). Our finding expands the phenotypic spectrum of the recently identified FHL1-associated myopathies and widens the differential diagnosis of Emery-Dreifuss-like syndromes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186852     DOI: 10.1002/ana.21839

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands.

Authors:  Anne T Bertrand; Carsten G Bönnemann; Gisèle Bonne
Journal:  Neuromuscul Disord       Date:  2014-02-14       Impact factor: 4.296

Review 2.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

3.  Fhl1 W122S causes loss of protein function and late-onset mild myopathy.

Authors:  Valentina Emmanuele; Akatsuki Kubota; Beatriz Garcia-Diaz; Caterina Garone; Hasan O Akman; Daniel Sánchez-Gutiérrez; Luis M Escudero; Shingo Kariya; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2014-09-30       Impact factor: 6.150

4.  Phenotypic heterogeneity in British patients with a founder mutation in the FHL1 gene.

Authors:  Anna Sarkozy; Christian Windpassinger; Judith Hudson; Charlotte F Dougan; Bryan Lecky; David Hilton-Jones; Michelle Eagle; Richard Charlton; Rita Barresi; Hanns Lochmüller; Kate Bushby; Volker Straub
Journal:  Eur J Hum Genet       Date:  2011-06-01       Impact factor: 4.246

5.  Genetic Variations of Ultraconserved Elements in the Human Genome.

Authors:  Anamarija Habic; John S Mattick; George Adrian Calin; Rok Krese; Janez Konc; Tanja Kunej
Journal:  OMICS       Date:  2019-11

Review 6.  Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies.

Authors:  Babken Asatryan; Argelia Medeiros-Domingo
Journal:  J Mol Med (Berl)       Date:  2018-08-20       Impact factor: 4.599

7.  FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy.

Authors:  ZhenXian Hu; Ying Zhu; Xiao Liu; Wei Zhang; Jing Liu; Shiwen Wu; Jiangxi Xiao; Yun Yuan; Zhaoxia Wang
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

8.  Identification of an FHL1 protein complex containing ACTN1, ACTN4, and PDLIM1 using affinity purifications and MS-based protein-protein interaction analysis.

Authors:  Parveen Sharma; Thiruchelvi Shathasivam; Vladimir Ignatchenko; Thomas Kislinger; Anthony O Gramolini
Journal:  Mol Biosyst       Date:  2011-01-18

Review 9.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Curr Opin Neurol       Date:  2008-10       Impact factor: 5.710

10.  Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.

Authors:  Yuan Xue; Benedikt Schoser; Aliz R Rao; Roberto Quadrelli; Alicia Vaglio; Verena Rupp; Christine Beichler; Stanley F Nelson; Gudrun Schapacher-Tilp; Christian Windpassinger; William R Wilcox
Journal:  Circ Cardiovasc Genet       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.